A Glimpse Into The Expert Outlook On AnaptysBio Through 6 Analysts
A Glimpse Into The Expert Outlook On AnaptysBio Through 6 Analysts
六位分析師對anaptysbio的專家觀點一窺究竟
The analysis of recent analyst actions sheds light on the perception of AnaptysBio by financial experts...In the latest quarter, 6 analysts provided ratings for AnaptysBio (NASDAQ:ANAB), showcasing a mix of bullish and bearish perspectives.
在最新季度，6位分析師爲anaptysbio（納斯達克：ANAB）提供了評級，展示了一些看好和看淡的觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估，下表展示了過去30天內不斷變化的情緒，並將其與之前的幾個月進行了比較。
Analysts have set 12-month price targets for AnaptysBio, revealing an average target of $57.83, a high estimate of $90.00, and a low estimate of $30.00. Marking an increase of 9.8%, the current average surpasses the previous average price target of $52.67.
分析師爲AnaptysBio設定了12個月的價格目標，顯示平均目標爲57.83美元，高估爲90.00美元，低估爲30.00美元。當前平均目標較之前的52.67美元有9.8%的增長。
Breaking Down Analyst Ratings: A Detailed Examination
分析師評級分析：詳細分析
The analysis of recent analyst actions sheds light on the perception of AnaptysBio by financial experts...
最近分析師行動的分析揭示了金融專...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間